1.
American cancer society,
“Cancer facts & figures 2017.”
2.
“http://www.cancerresearchuk.org/about-cancer/ovarian-cancer/survival,” consulted in September 2017.
3.
SEER Cancer Stat Facts: Ovarian Cancer.
National Cancer Institute.,” Bethesda,
MD,
http://seer.cancer.gov/statfacts/html/ovary.htmle.
Accessed in October 2017.
4.
A.
Peces Rama,
M.
C.
Llanos Llanos,
M.
L.
Sanchez Ferrer,
J.
L.
Alcazar Zambrano,
A.
Martinez
Mendoza,
and A.
Nieto Diaz,
“Simple descriptors and simple rules of the International OvarianTumor Analysis (IOTA) Group: a prospective study of combined use for the description of adnexal masses.,” Eur.
J.
Obstet.
Gynecol.
Reprod.
Biol.,
vol.
195,
pp.
7–11,
Dec.
2015.
5.
K.
G.
Araujo et al.,
“Performance of the IOTA ADNEX model in preoperative discrimination of
adnexal masses in a gynecological oncology center.,” Ultrasound Obstet.
Gynecol.,
vol.
49,
no.
6 pp.
778–783,
Jun.
2017.
6.
D.
Timmerman et al.,
“Simple ultrasound-based rules for the diagnosis of ovarian cancer.,
7.
R.
Forstner,
E.
Sala,
K.
Kinkel,
and J.
A.
Spencer,
“ESUR guidelines: Ovarian cancer staging and
follow-up,” Eur.
Radiol.,
vol.
20,
no.
12,
pp.
2773–2780,
2010
8.
D.
G.
Mitchell et al.,
“ACR appropriateness criteria staging and follow-up of ovarian cancer.,” J.Am.
Coll.
Radiol.,
vol.
10,
no.
11,
pp.
822–827,
Nov.
2013
9.
A.
B.
Kurtz et al.,
“Diagnosis and Staging of Ovarian Cancer: Comparative Values of Doppler and Conventional US,
CT,
and MR Imaging Correlated with Surgery and Histopathologic Analysis— Report of the Radiology Diagnostic Oncology Group,” Radiology,
vol.
212,
no.
1,
pp.
19–27,
Jul.
1999
10.
J.
Prat,
“Staging classification for cancer of the ovary,
fallopian tube,
and peritoneum,” Int.
J.
Gynecol.
Obstet.,
vol.
124,
no.
1,
pp.
1–5,
2014
11.
P.
J.
Woodward,
K.
Hosseinzadeh,
and J.
S.
Saenger,
“From the archives of the AFIP: radiologicstaging of ovarian carcinoma with pathologic correlation.,” Radiographics,
vol.
24,
no.
1,
pp.
225–246,
2004.
12.
http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancertype/ovarian-cancer/incidence#heading-Three,” Consult.
Sept.
2017.
13.
K.
Michielsen et al.,
“Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer,” Eur.
J.
Cancer,
vol.
83,
pp.
88–98,
2017
14.
G.
Glaser et al.,
“The use of CT findings to predict extent of tumor at primary surgery for ovarian cancer,” Gynecol.
Oncol.,
vol.
130,
no.
2,
pp.
280–283,
2013
15.
M.
Espada et al.,
“Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma,” Eur.
Radiol.,
vol.
23,
no.
9,
pp.
2636–2642,
2013.
16.
S.
Motoshima,
H.
Irie,
T.
Nakazono,
T.
Kamura,
and S.
Kudo,
“Diffusion-weighted MR imaging
in gynecologic cancers,” Journal of Gynecologic Oncology,
vol.
22,
no.
4.
pp.
275–287,
2011.